Furthermore, while normal human tissues exhibit limited expression of Trop2 [19], in breast cancer, Trop2 expression was observed to be more pronounced [20]; thus, the use of Trop2 presents a potential targeting module for diagnosis or tumor therapy. The gene discussed is TACSTD2; the disease is breast carcinoma.